Cargando…
Activation of Insulin-Reactive CD8 T-Cells for Development of Autoimmune Diabetes
OBJECTIVE: We have previously reported a highly diabetogenic CD8 T-cell clone, G9C8, in the nonobese diabetic (NOD) mouse, specific to low-avidity insulin peptide B15-23, and cells responsive to this antigen are among the earliest islet infiltrates. We aimed to study the selection, activation, and d...
Autores principales: | Wong, F. Susan, Khai Siew, Lai, Scott, Gwen, Thomas, Ian J., Chapman, Stephen, Viret, Christophe, Wen, Li |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671054/ https://www.ncbi.nlm.nih.gov/pubmed/19208910 http://dx.doi.org/10.2337/db08-0800 |
Ejemplares similares
-
A reproducible method for the expansion of mouse CD8 + T lymphocytes
por: Lewis, Mark D., et al.
Publicado: (2015) -
Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8(+) T Cells
por: Pearson, James A., et al.
Publicado: (2016) -
Combination Treatment With Anti-CD20 and Oral Anti-CD3 Prevents and Reverses Autoimmune Diabetes
por: Hu, Changyun, et al.
Publicado: (2013) -
Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes
por: Wenzlau, Janet M., et al.
Publicado: (2022) -
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8(+) T Cells
por: Overwijk, Willem W., et al.
Publicado: (2003)